Korro Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Korro Bio and other ETFs, options, and stocks.About KRRO
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.
CEORam Aiyar
CEORam Aiyar
Employees58
Employees58
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees58
Employees58
KRRO Key Statistics
Market cap184.75M
Market cap184.75M
Price-Earnings ratio-1.03
Price-Earnings ratio-1.03
Dividend yield—
Dividend yield—
Average volume72.31K
Average volume72.31K
High today$13.13
High today$13.13
Low today$12.68
Low today$12.68
Open price$12.74
Open price$12.74
Volume52.32K
Volume52.32K
52 Week high$55.89
52 Week high$55.89
52 Week low$5.20
52 Week low$5.20
Stock Snapshot
The current Korro Bio(KRRO) stock price is $12.80, with a market capitalization of 184.75M. The stock trades at a price-to-earnings (P/E) ratio of -1.03.
On 2026-04-28, Korro Bio(KRRO) stock moved within a range of $12.68 to $13.13. With shares now at $12.80, the stock is trading +0.9% above its intraday low and -2.5% below the session's peak.
Trading activity shows a volume of 52.32K, compared to an average daily volume of 72.31K.
The stock's 52-week range extends from a low of $5.20 to a high of $55.89.
The stock's 52-week range extends from a low of $5.20 to a high of $55.89.
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own KRRO. This list is generated using Robinhood data, and it’s not a recommendation.